Rankings / Cognitive

Vinpocetine

Cognitive · Cerebral vasodilator

Tier C+

anti-inflammatoryprescriptionotc
5.6 / 10
Tier C+
Ev 4.5 Bn 5 Sf 7

Bottom line

Read Off Label grades Vinpocetine as C+ (5.6/10) based on weak-moderate evidence, med benefit magnitude, and a low-med-risk safety profile.

FDA 2019 statement that vinpocetine does not meet dietary supplement criteria (it's a synthetic drug).

Typical use: 15-45 mg/day PO divided — Rx in EU/Asia; OTC US though FDA has warned against supplement sale.

What this is

FDA 2019 statement that vinpocetine does not meet dietary supplement criteria (it's a synthetic drug). Still widely sold OTC. Cavinton approved in ~50 countries for cerebrovascular indications. Evidence quality mixed. Avoid in pregnancy — uterotonic.

Mechanism

Synthetic derivative of vincamine (from Vinca minor); PDE1 inhibitor; sodium channel blocker; increases cerebral blood flow; anti-inflammatory

Dose & route

15-45 mg/day PO divided

Common questions

Does Vinpocetine work?
Read Off Label rates the evidence for Vinpocetine as Weak-Moderate and the benefit magnitude as med, producing an overall grade of C+ (5.6/10). FDA 2019 statement that vinpocetine does not meet dietary supplement criteria (it's a synthetic drug).
Is Vinpocetine safe?
Vinpocetine has a low-med risk profile in published human data. Legal status: Rx in EU/Asia; OTC US though FDA has warned against supplement sale. This is not medical advice — see the disclaimer.
What is the typical dose for Vinpocetine?
15-45 mg/day PO divided
How does Vinpocetine work?
Synthetic derivative of vincamine (from Vinca minor); PDE1 inhibitor; sodium channel blocker; increases cerebral blood flow; anti-inflammatory

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.